ATTO (Attovia Therapeutics) Marketable Securities: $89.33 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $20.38
View Full Analysis

What is Attovia Therapeutics Marketable Securities?

Attovia Therapeutics ATTO -6.94% 8 Marketable Securities is $89.33 Mil as of Mar. 2026. GuruFocus rates ATTO with a GF Score™ of 8/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Attovia Therapeutics's Marketable Securities for the quarter that ended in Mar. 2026 was $89.33 Mil.

Attovia Therapeutics's annual Marketable Securities increased from . 20 ($0.00 Mil) to Dec. 2024 ($38.69 Mil) and increased from Dec. 2024 ($38.69 Mil) to Dec. 2025 ($112.08 Mil).

Attovia Therapeutics  (NAS:ATTO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Attovia Therapeutics Marketable Securities Related Terms

Attovia Therapeutics Marketable Securities Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics Marketable Securities Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
Marketable Securities
38.69 112.08

Attovia Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Marketable Securities 38.69 0.00 112.08 89.33
ATTO
8GF Score
Attovia Therapeutics Inc ATTO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $89.33 Mil mean?
Attovia Therapeutics (ATTO) has a Marketable Securities of $89.33 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Attovia Therapeutics and its competitors.
Is Attovia Therapeutics' Marketable Securities too high?
Attovia Therapeutics' current Marketable Securities is $89.33 Mil. Overall, Attovia Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Attovia Therapeutics' Marketable Securities compare to ?
Attovia Therapeutics' Marketable Securities of $89.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Attovia Therapeutics and its competitors. Attovia Therapeutics's current Marketable Securities is $89.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attovia Therapeutics stock overvalued right now?
Attovia Therapeutics (ATTO) has a current Marketable Securities of $89.33 Mil. The current Marketable Securities is $89.33 Mil. Attovia Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Attovia Therapeutics (ATTO), the current Marketable Securities is $89.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attovia Therapeutics Business Description

Comparable Companies
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.38
Price